Notable difference was reported in serum ApoB/ApoA1 ratio between LC and HCC patients at different stages, and combined diagnosis with AFP exhibited the capability of increasing the detection efficacy and specificity of AFP for HCC and AFP-negative HCC. This evidence concerns the gene APOA1 and laryngotracheoesophageal cleft.